Clinical Validation Study Update
April 1, 2022
Strategic decision to expand study without impacting commercial pathway
Keep Reading
TR-1: Standard form for notification of major holdings
March 23, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 21, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 18, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 16, 2022
Notification of major holdings
Keep Reading
TR-1: Standard form for notification of major holdings
March 15, 2022
Notification of major holdings
Keep Reading
Close of Subscription and Fundraise Update
March 11, 2022
The Subscription has now closed and the Fundraise has successfully concluded, save for Admission.
Keep Reading
Fundraise - Successful Placing
March 4, 2022
Verici Dx is pleased to announce the successful completion of the Placing.
Keep Reading
Close of Accelerated Bookbuild
March 4, 2022
Further to the announcement made at 7.10 a.m. today, the Placing has now closed and the Bookbuild has been successfully concluded.
Keep Reading
Proposed Fundraise to raise not less than £10.0 million (approximately $13.3 million)
March 4, 2022
Verici Dx announces its intention to conduct a fundraise through the non pre-emptive issue of at least 28,571,429 new ordinary shares
Keep Reading
« Previous
1
2
3
4
5
6
…
8
Next »